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NAC  changes  oxidative  parameters  in  spinal  cord  of  CCI  rats.
NAC  has  antinociceptive  effect  in  rats  with  chronic  constriction  of  sciatic  nerve.
NAC  decrease  nitric  oxide  metabolites  in spinal  cord  of  CCI  rats.
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a  b  s  t  r  a  c  t
Since  N-acetylcysteine  (NAC)  is  a  donor  of  cysteine,  we studied  the  relationship  between  NAC and  con-
centration  of  oxidized  and  reduced  glutathione  (GSH/GSSG  ratio),  and  glutathione  peroxidase  (GPx) and
glutathione-S-transferase  (GST)  activities  in  the  lumbosacral  spinal  cord  of rats  with  chronic  constriction
injury  (CCI) of  the sciatic  nerve  that  received  NAC  (150  mg/kg/day,  i.p.)  or 0.9%  saline  solution  for  3 or  10
days.  Hydrogen  peroxide  (H2O2) and nitric-oxide  (NO)  metabolites  were  also  measured.  Von  Frey  hair
and hot-plate  tests  showed  hyperalgesia  at day  1  in CCI rats. Hyperalgesia  persisted  at  all  other  times  in
saline-treated  CCI  rats,  but returned  to  pre-injury  values  in  NAC-treated  CCI  rats  after  3 postoperativexidized and reduced glutathione
ydrogen peroxide
hronic constriction
ciatic nerve
days.  GST  activity  and  the  GSH/GSSG  ratio increased  in  saline-treated  CCI rats,  while  the NAC  treatment
increased  GST  and  GPx  activities  at day  10,  with  no signiﬁcant  change  in  the  GSH/GSSG  ratio.  NAC  treat-
ment  did  not  affect  H2O2 levels,  but it reduced  NO  metabolites  in CCI rats  3 days  after  the  surgery.  Thus,
the  anti-hyperalgesic  effect  of  NAC  appears  not  to  involve  its  action  as a cysteine  precursor  for  GSH
synthesis,  but  involves  a decrease  in  NO.
© 2014  Elsevier  Ireland  Ltd.  All  rights  reserved.. Introduction
N-acetylcysteine (NAC) produces a broad range of effects, which
nclude reduction in pain [1] and neuroprotection after spinal cord
njury [2] and peripheral nerve lesion [3–5]. The beneﬁcial effects of
AC appear to include modulation of the antioxidant redox system,
eduction in several neuroinﬂammatory molecules, and decrease in
itric oxide [6,7].
NAC is a cysteine donor. Cysteine can cross the cell membrane
nd support the synthesis of glutathione (GSH) [8], which is a sub-
trate of antioxidant enzymes such as glutathione peroxidase (GPx)
nd glutathione-S-transferase (GST). GPx catalyzes the reduction
∗ Corresponding author. Tel.: +55 51 3308 3305; fax: +55 51 3308 3166.
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ttp://dx.doi.org/10.1016/j.neulet.2014.03.063
304-3940/© 2014 Elsevier Ireland Ltd. All rights reserved.of hydrogen peroxide (H2O2) and organic hydroperoxides at the
expense of GSH [9]. GST plays a role in the detoxiﬁcation of
xenobiotics and products of lipoperoxidation [10]. The oxida-
tion of GSH leads to the production of glutathione disulﬁde
(GSSG). The GSH/GSSG pair forms the major redox couple in
cells [11].
Since CCI can decrease GSH [1] and increase NO [12] in
nerve tissue, we postulated that the analgesic effect of NAC
would involve modulation of the GSH and NO in the spinal
cord. Thus, our study assessed the relationship between mechan-
ical and thermal hyperalgesia evoked by CCI and alterations in
the GSH/GSSG ratio, GPx and GST activities and NO metabo-
lites in the lumbosacral spinal cord of rats with CCI treated
with NAC (150 mg/kg/d) for 3 or 10 days. Since peripheral nerve
injury changes spinal-cord hydrogen peroxide (H2O2) levels and
NAC reacts slowly with H2O2 [7], our study also determined
164 A. Horst et al. / Neuroscience Letters 569 (2014) 163–168
Fig. 1. Assessment of behavioral hypersensitivity after chronic constriction injury (CCI) of the sciatic nerve in rats treated with N-acetylcysteine (NAC) (150 mg/kg/day, i.p.) for
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e or 10 days. Graphs show the mechanical hypersensitivity measured by von Frey te
or  each group). * Indicates a signiﬁcant difference compared to pre-nerve lesion v
AC-treated naive rats; Sham-s, saline-treated sham rats; Sham-n, NAC-treated sha
he levels of H2O2 in the spinal cord of the animals. We  also
valuated blood parameters including gamma-glutamyltransferase
gamma-GT), aspartate aminotransferase (AST), alanine amino-
ransferase (ALT), bilirubin, and creatinine, as well as hepatocyte
orphology, because NAC treatment is associated with mild side
ffects [8].and the latency time against heat stimuli (B). Data represent the means ± SEM (n = 6
 (repeated-measures ANOVA, p < 0.05). Naive-s, saline-treated naive rats; Naive-n,
s; CCI-s, saline-treated CCI rats; CCI-n, NAC-treated CCI rats.
2. Materials and methods2.1. Animals
All animal procedures were approved by the Ethics Committee
of the Federal University of Rio Grande do Sul (#19037). Adult male
A. Horst et al. / Neuroscience Letters 569 (2014) 163–168 165
Fig. 2. GSH/GSSG ratio in the spinal cord of rats with chronic constriction injury
(CCI) of the sciatic nerve treated with N-acetylcysteine (NAC) (150 mg/kg/day, i.p.)
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Fig. 3. GPx (A) and GST (B) activities in the spinal cord of rats with chronic
constriction injury (CCI) of the sciatic nerve treated with N-acetylcysteine (NAC)
(150 mg/kg/day, i.p.) for 3 or 10 days. Data represent the means ± SEM (n = 6 for each
group). (a) Indicates a signiﬁcant difference compared to naive and Sham groups.
(b)  Indicates a signiﬁcant difference compared to naive and CCI groups. (c) Indicatesor  3 or 10 days. Data represent the means ± SEM (n = 6 for each group). (a) Indicates
 signiﬁcant difference compared to naive and Sham groups (three-way ANOVA
ollowed by Tukey post-hoc test, p < 0.05).
istar rats, weighing 200–300 g, were divided into three exper-
mental groups (Naive, Sham and CCI, n = 24 in each group), and
ach was further divided into four subgroups (n = 6 in each sub-
roup), which received NAC ((Fluimucil®, Zambon Laboratórios
armacêuticos) at a dose of 150 mg/kg/d or 0.9% saline solution,
ntraperitoneally, for 3 or 10 d. The administration started 4 h after
he surgical procedure and continued once daily until termina-
ion, using a technique described elsewhere [3,5]. Rats were not
nesthetized during the injections.
.2. Induction of chronic constriction injury (CCI)
After anesthesia (90 mg/kg ketamine and 10 mg/kg xylazine),
he right common sciatic nerve was exposed proximal to its tri-
urcation, and four ligatures (4.0 Shalon Chromic Catgut) were tied
oosely around it as described by Bennett and Xie [13] with slight
odiﬁcations according to Goecks et al. [14]. To expose the sciatic
erve in Sham rats, all surgical procedures involved in CCI were
sed except the ligature.
.3. Behavioral assessment
Rats were subjected to sensitivity assessments before the surgi-
al procedure (day 0) and at 1, 3, 5, 7 and 10 days after surgery. To
easure mechanical sensitivity, responses of the injured hind paw
o a range of applied innocuous von Frey ﬁlaments (North Coast
edical, Inc., USA) were evaluated. The minimum and maximum
timulus intensity was 1 g and 64 g, respectively. The ﬁrst stim-
lus was always initiated with the lowest ﬁlament. If there was
o positive response, the next higher ﬁlament was  applied. This
esting pattern was continued until a withdrawal response was
ecorded [14]. Thermal hyperalgesia was measured by placing the
ats on a hot plate maintained at 50 ◦C (±2 ◦C). Withdrawal latency
as considered as when the animal jumped or licked a hind paw,
ndependently of side..4. Sample preparation
Rats were killed by decapitation and their lumbosacral spinal
ord was promptly dissected out and divided transversely intoa  signiﬁcant difference compared to naive group (three-way ANOVA followed by
Tukey post-hoc test, p < 0.05).
three parts. The same portion always received the same prepa-
ration. One part was cooled in liquid nitrogen and processed to
determine H2O2. Another part was homogenized in 1.15% KCl
diluted 1:5 (w/v) containing 1 mmol/L phenylmethylsulfonyl ﬂu-
oride, centrifuged at 800 × g for 20 min  at 4 ◦C, and the supernatant
was used for assays of GPx and GST activities and NO metabolites.
A third part was  deproteinized with 2 mol/L perchloric acid, cen-
trifuged for 10 min  at 1000 × g, and the supernatant was neutralized
with 2 mol/L KOH and used to determine the GSH/GSSG ratio.
The blood was  centrifuged for 20 min  at 1000 × g and the plasma
used to determine gamma-GT, AST, ALT, bilirubin and creatinine.
Commercially available kits (LABTEST) were used for these assays.
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Fig. 4. Hydrogen peroxide (A) and nitric oxide metabolites (nitrites + nitrates) (B)
in  the spinal cord of rats with chronic constriction injury (CCI) of the sciatic nerve
treated with N-acetylcysteine (NAC) (150 mg/kg/day, i.p.) for 3 or 10 days. Data rep-
resent the means ± SEM (n = 6 for each group). (a) Indicates a signiﬁcant difference
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Table 1
Effect of the treatment with N-acetylcysteine (NAC) (150 mg/kg/day, i.p.) by 10 days
on rat blood parameters.
Saline NAC
TGO (mmol/L) 103.66 ± 4.50 120.61 ± 9.89
TGP  (mmol/L) 55.81 ± 2.78 57 ± 5.50
GAMA-GT (mmol/L) 54.21 ± 9.18 29.86 ± 4.22
Total bilirrubin (mmol/L) 1.08 ± 0.10 1.16 ± 0.15
Direct bilirrubin (mmol/L) 0.75 ± 0.17 1.11 ± 0.14
Creatinine (mmol/L) 0.12 ± 0.04 0.11 ± 0.04
spinal cord of the saline-treated rats. This increase was  not presentompared to naive and Sham groups. (b) Indicates a signiﬁcant difference compared
o naive group (three-way ANOVA followed by Tukey post-hoc test, p < 0.05).
iver samples were immersed in Bouin solution, embedded in
arafﬁn, and cut in 20 m sections. Staining was done using the
ematoxylin and eosin method.
.5. Determination of antioxidant activities, H2O2 and NO
etabolites
GPx activity was measured by following the nicotinamide dinu-
leotide phosphate acid (NADPH) oxidation at 340 nm [15]. GST
ctivity was measured by the rate of formation of dinitrophenyl-
-glutathione at 340 nm [16]. The GSH/GSSG ratio was determined
ased on the procedure described by Akerboom and Sies [17].TGO: aspartate amino transferase.
TGP: alanine amino transferase.
GAMA-GT: gamma-glutamyltransferase.
The assay for H2O2 was  based on the procedure described by
Guedes et al. [18]. To measure NO metabolites, the Griess reagent
was used [19].
2.6. Protein measurement
Protein was measured by the method of Lowry et al. [20], using
bovine serum albumin as the standard.
2.7. Statistical analysis
The biochemical results were analyzed using three-way ANOVA
(factors: lesion, treatment and time) followed by Tukey post-hoc
test. The results of the von Frey and hot-plate tests were analyzed
by repeated measures ANOVA. Differences were considered statis-
tically signiﬁcant when p was <0.05.
3. Results
3.1. Behavioral assessment
One day after CCI, all CCI and Sham rats showed mechani-
cal (Fig. 1A) and thermal hyperalgesia (Fig. 1B). This response
was not found at the other times in the Sham groups. At day 3
postoperatively, the administration of NAC attenuated mechani-
cal and thermal hyperalgesia. This effect was  also found at days 5,
7 and 10. The sensitivities remained higher in saline-treated CCI
rats.
3.2. Effects on antioxidant, oxidative and nitrosative parameters
At day 3, the spinal-cord GSH/GSSG ratio increased (13%) in the
saline-treated CCI rats. This increase was not found at day 10. No
increase occurred when NAC was administered to CCI rats (Fig. 2).
No change was  found in Sham animals.
While no change was  found in GPx activity in the CCI groups at
day 3, the activity of this enzyme was  increased (40%) in the NAC-
treated CCI group at day 10 (Fig. 3A). GPx activity did not change in
the Sham groups at day 3. However, an increase (56%) was found
in saline-treated Sham rats at day 10.
GST activity increased (100%) in saline-treated CCI animals at
day 3, but not in animals that received NAC treatment (Fig. 3B). At
10 days, a signiﬁcant increase (50%) was  found only in NAC-treated
CCI rats. No signiﬁcant change occurred in the Sham groups.
At days 3 and 10 post-CCI, H2O2 levels were signiﬁcantly
reduced in the spinal cord (Fig. 4A). NAC did not change this param-
eter. H2O2 levels did not change in Sham rats.
Three days after CCI, NO metabolites were higher (192%) in thein the group that received NAC, which showed a reduction of around
20% (Fig. 4B). Whereas no change was found in saline-treated Sham
rats at day 3, NAC administration caused a reduction (33%) in NO
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[ig. 5. Cross sections of the liver from rats without (A) and with chronic constrictio
 (B) or 10 (C) days. Liver sections were stained with hematoxylin and eosin. Calibr
etabolites in these rats. At day 10, no signiﬁcant change was found
n the CCI and Sham groups.
.3. Effects on plasmatic and histopathological parameters
Gamma-GT, AST, ALT, bilirubin and creatinine levels did not
hange with NAC administration (Table 1). No change was  found
n liver morphology (Fig. 5).
. Discussion
The analgesic effect of NAC is in line with previous studies [1,21].
owever, it differs from a recent study where injections of NAC did
ot induce analgesia in CCI mice [22]. Although further studies are
eeded to explain this difference, the species used should be con-
idered. Neuropathic pain behavior varies widely, not only between
nbred and outbred strains, but also even between substrains [23].
While CCI elevated the GSH/GSSG ratio, this increase was not
bserved in animals that received NAC. NAC appears to have
ntioxidant activity [8], which may  have contributed to the lack
f increase in the ratio. However, injections of NAC reduced
he expression of the catalytic subunit of the cystine/glutamate
ntiporter in the spinal cord [22]. Extracellular glutamate lev-
ls released as a consequence of increased cystine/glutamate
ntiporter activity are balanced by glutamate transporter activ-
ty, and the glutamate-induced GSH depletion is markedly reduced
24]. It has been demonstrated that CCI induces upregulation in the
RNA expression of the spinal glutamate transporters [25], and
he expression and activity of the cysteine/glutamate antiporter
re increased against a rise in NO and reactive oxygen species [24],
hich are increased in pain conditions [26]. Therefore, the coop-
rative action of the cystine/glutamate antiporter and excitatory
mino-acid transporters may  have contributed to GSH biosynthesis
n the spinal cord of the saline-treated CCI rats.
NAC, in turn, decreased NO metabolites in spinal cord of the
AC-treated CCI and sham rats. NAC exerts a strong inhibitory
ffect on the expression of the inducible nitric oxide synthase
iNOS) gene, one of the enzymes that catalyze NO production [7].
his effect might have contributed to the reduction in NO. Since
NOS increases in the spinal cord after CCI [12] and this enzyme
lays a role in the nociceptive process [27], its reduction might
ave contributed to the anti-hyperalgesic effect of the NAC. How-
ver, NAC appears to suppress the c-Jun N-terminal kinase and
38 proteins, which are involved in the induction of peripheral
nd central sensitization that occurs in pain [28,29]. Thus, at the
oment it is impossible to identify the factors involved in the anal-
esic effect of NAC. Research on this question is under way  in our
aboratory.NAC induced a late increase in GPx activity in CCI rats. The
ack of change at day 3 may  be due to an increase in the cata-
ase activity induced by CCI [14]. It may  have contributed to the
vailability of GSH to maintain optimum intracellular conditions.
[ry (CCI) of the sciatic nerve treated with N-acetylcysteine (150 mg/kg/day, i.p.) for
bar: 5 m (A–C).
The increase in GPx activity in the saline-treated sham rats at day
10 may  be related to the increase (398%) in lipid hydroperoxides
[14]. The recruitment of GST activity at day 3 would contribute to
prevent the establishment of an oxidative stress condition in saline-
treated CCI rats. In these rats, the lipid hydroperoxides increased
in this period [14]. The GST increase in NAC-treated CCI rats may
be related to cell detoxiﬁcation, due to the longer time period of
the treatment.
The reduction in the H2O2 levels was  related to neuropathic pain
and not to the NAC treatment. NAC reacts slowly with H2O2 and this
route appears to be insigniﬁcant under physiological conditions [8],
which explains the lack of a relationship between NAC and H2O2.
The lack of changes in the plasma indicators and hepatocyte
morphology suggests that NAC treatment appears not to have a
toxic effect at the dose used in our study.
Thus, our study suggests that the anti-hyperalgesic effect of NAC
does not involve its action as a cysteine precursor for GSH synthesis,
but does involve a decrease in NO.
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